Agenus Inc. Faces Class Action Lawsuit
Investors in Agenus Inc. have been made aware of a class action lawsuit that offers them a chance to take action against the company. This lawsuit targets AGEN, the stock ticker symbol, along with several of its executives for alleged violations of federal securities laws.
Understanding the Class Action
Class action lawsuits provide a collective approach for investors who have experienced losses. The suit against Agenus specifically concerns all individuals and entities that acquired Agenus securities during a defined period, which starts on January 23, 2023, and ends on July 17, 2024. Investors who believe they’ve been wronged are encouraged to explore their options for joining this legal action.
Reason for the Lawsuit
The allegations in this lawsuit raise significant concerns against Agenus. It claims that the executives misled investors with statements about their products, particularly the combination therapy involving botensilimab and balstilimab. Reports suggest these therapies were not as effective as claimed, implying that the company may have overstated its clinical results, regulatory prospects, and overall commercial viability.
What Investors Should Do
If you are impacted, it is essential to act promptly. Although a class action lawsuit has already begun, interested investors can look over the details of the Complaint and decide if they want to join in. Consulting with experienced legal counsel can clarify individual rights and the possibility of recovering losses.
Your Rights as an Investor
Investors should know that joining a class action does not require upfront costs. The law firm representing the class works on a contingency basis, which means they only get paid if there’s a successful resolution.
No Financial Risk Involved
This arrangement lifts the financial burden off individual investors, permitting them to seek justice without worrying about upfront legal fees. Investors can be confident that legal costs will only apply if they are part of the class action and the case is resolved successfully.
Why Choose Bronstein, Gewirtz & Grossman, LLC
Bronstein, Gewirtz & Grossman, LLC is a well-known law firm specializing in securities fraud. They have a proven track record of securing substantial recoveries for investors and bring extensive experience to the table. Their dedication to representing investor rights in class actions ensures that affected individuals have a reliable ally in their pursuit of justice.
Contact Information
Investors who have suffered losses with Agenus Inc. should get in touch with Bronstein, Gewirtz & Grossman, LLC directly. For inquiries, reach out to Peretz Bronstein or Nathan Miller at 332-239-2660. They are ready to assist and answer any questions related to the lawsuit and investor rights.
Frequently Asked Questions
What is a class action lawsuit?
A class action lawsuit enables a group of people with similar legal claims to file a case together, streamlining the legal proceedings.
How do I know if I qualify to join the class action against Agenus?
If you bought Agenus securities during the specified period and think you’ve suffered losses, you may qualify to join the lawsuit.
What happens if I join the lawsuit?
By joining the lawsuit, you'll be part of a larger group pursuing damages. You won’t have to cover legal costs unless the case is successful.
Will I need to appear in court?
In general, individual plaintiffs don’t need to appear in court because class actions are usually managed by the appointed lead plaintiff and their lawyer.
How can I get more information about the case?
For further details, you can contact Bronstein, Gewirtz & Grossman, LLC directly or visit their website for updates on the class action.
